Key Takeaways:
- Skeletal muscle hypertrophy is driven primarily by testosterone—not dihydrotestosterone (DHT)—binding androgen receptors in muscle fibers.
- Because finasteride blocks testosterone-to-DHT conversion, circulating serum testosterone typically stays stable or rises modestly (~10%–15%) within normal limits.
- Controlled trials—even using 5x higher prostate doses (5 mg daily)—show zero loss of lean muscle mass, leg press strength, or physical performance.
- Training progressive overload, sleep, and daily protein intake govern your physique; finasteride 1 mg protects scalp follicles without blunting gym gains.
Testosterone vs. DHT in Skeletal Muscle Biology
Men starting finasteride 1 mg often worry that blocking an androgen might hurt strength or lean mass. Biologically, skeletal muscle tissue contains very little 5-alpha-reductase enzyme—meaning testosterone itself (rather than DHT) is the primary anabolic hormone driving muscle protein synthesis, while DHT acts predominantly in scalp follicles, skin, and prostate tissue.
What Clinical Trials Measuring Strength & Body Composition Found
- 3,040-patient clinical data (5 mg finasteride): Showed a slight rise in circulating serum testosterone—most noticeable in men with lower baseline levels—with no adverse body-composition shifts.
- Controlled strength & lean-mass trial: Men receiving testosterone with vs. without 5 mg daily finasteride experienced a ~50%+ drop in serum DHT yet achieved identical gains in lean body mass, grip strength, and physical performance.
Since hair-loss therapy uses just 1 mg daily (one-fifth the BPH dose studied), clinically meaningful muscle loss is unsupported by evidence.
Side Effects Actually Worth Monitoring
While muscle mass is unaffected, a small minority of men (~1%–2%) may notice reversible sexual side effects (lower libido or softer erections) or rare breast tenderness due to minor aromatization shifts, or mood changes—always report new symptoms promptly to your prescribing clinician.
Leave a Reply